Innovation throughout a medicine’s lifecycle is vital to bringing new solutions to address gaps in healthcare
Brussels, 30 November 2022
The added value of innovating on existing medicines may be in finding a new indication, by treating a different disease with the same medicine or treating a specific sub-population, improving efficacy of the treatment, being easier to tolerate, or improving overall adherence.